SCHEMBL31376352

SCHEMBL31376352

c1cc2ccc3cc4c5ccccc5[nH]c4c4ccc(c1)c2c34

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 3/20 0.61
AHR P35869 3/20 0.53
CYP1A2 P05177 2/20 0.53
ERBB2 P04626 1/20 0.53
FYN P06241 1/20 0.53
MAOA P21397 1/20 0.53
ACHE P22303 1/20 0.53
GABRP O00591 1/20 0.46
GABRD O14764 1/20 0.46
GABRA1 P14867 1/20 0.46
GABRB1 P18505 1/20 0.46
GABRG2 P18507 1/20 0.46
GABRB3 P28472 1/20 0.46
GABRA5 P31644 1/20 0.46
GABRA3 P34903 1/20 0.46
GABRA2 P47869 1/20 0.46
GABRB2 P47870 1/20 0.46
GABRA4 P48169 1/20 0.46
GABRE P78334 1/20 0.46
GABRA6 Q16445 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14460567 0.86 KIF11 (0.51) KIF11AHRCYP1A2ERBB2FYN
SCHEMBL14460537 0.86 KIF11 (0.51) KIF11AHRCYP1A2ERBB2FYN
SCHEMBL16001376 0.80 KIF11 (0.49) KIF11AHRGABRPGABRDGABRA1
Pyrene SCHEMBL2127931 0.80 ALDH1A1 (0.67) KIF11AHRCYP1A2ERBB2FYN
SCHEMBL18017188 0.79 CDK4 (0.54) KIF11CYP1A2GABRPGABRDGABRA1
SCHEMBL30439561 0.79 CDK4 (0.54) KIF11CYP1A2GABRPGABRDGABRA1
SCHEMBL14708661 0.78 AHR (0.55) KIF11AHRCYP1A2ERBB2FYN
SCHEMBL31376340 0.78 AHR (0.55) KIF11AHRCYP1A2ERBB2FYN
SCHEMBL27717804 0.78 KIF11 (0.57) KIF11AHRCYP1A2ERBB2FYN
SCHEMBL28995573 0.77 KIF11 (0.79) KIF11CYP1A2MAOAGABRPGABRD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260026186-A1 LIGHT-EMITTING ELEMENT, FUSED POLYCYCLIC COMPOUND FOR THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2026-01-22 US disclosed
US-20250107442-A1 LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE HETEROCYCLIC COMPOUND SAMSUNG DISPLAY CO., LTD. (KR) 2025-03-27 US disclosed
CN-119661569-A Light-emitting device, electronic apparatus, electronic device, and heterocyclic compound 三星显示有限公司 2025-03-21 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260026186-A1 LIGHT-EMITTING ELEMENT, FUSED POLYCYCLIC COMPOUND FOR THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE SAME CCNL2, NFE2L2, ESR2 KIF11 4251/4885AHR 69/4885CYP1A2 155/4885
US-20250107442-A1 LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE HETEROCYCLIC COMPOUND LAGE3, CRY1, ESR1 KIF11 3920/4885AHR 165/4885CYP1A2 28/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.